Report description
This report represents the global and regional analysis of Lenalidomide in terms of dosage, brands, strength, API, application wise segmentation, market size & market growth (in terms of value & volume) trends including forecasting upto 5 years. All the region wise segmentation of buyer supplier is described properly. The report focuses on the top continent Wise (North America, Europe, Japan, China and other regions (India, Southeast Asia, Central & South America, and Middle East & Africa) manufacturer & buyers also.
Lenalidomide Introduction
“Lenalidomide” is off-white to pale-yellow solid powder, soluble in organic solvent/water mixtures. Solubility was significantly lower in less acidic buffers, ranging from about 0.4 to 0.5 mg/mL. It is antitumor drug which function as immune regulation, antitumor & antigiogenesis. Lenalidomide is indicated for the treatment of multiple myeloma in combination with dexamethasone. It is also indicated for the treatment of patients with transfusion-dependent anemia due to low- or intermediate- risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenetic abnormality with or without additional cytogenetic abnormalities
Report highlights
- Provide manufacturing capacity, consumption, current & past status & also the forecasting upto 2021.
- Provide complete overview including type, application & forecast region.
- Provide complete analysis of API & formulation including brand names, strength & market overview.
- Provide focused analysis of key manufacturer with their production volume, market share & also help to identify market competition landscape with SWOT analysis.
- Historical, current and projected market size in terms of volume and value.
- Analyze the global & regional potential market, advantages, risk & opportunity.
- Identify significant trends and factors driving or inhibiting the market growth.
- In-depth coverage of complete market in terms of supplier, buyer, price, trend, growth & forecasting.
The report covers Lenalidomide types
- 5 mg Capsules
- 10 mg Capsules
- 15 mg Capsules
- 25 mg Capsules
The report covers Lenalidomide applications
- Cancer Disease
- Cardiovascular Disease
- Immune Disease
The report covers exhaustive analysis on
- Market Segments
- Market Dynamics
- Brands In Market
- Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved
- Forecasting
- Technology
The report includes Regional analysis on
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of Latin America)
- Europe (Germany, Italy, France, U.K, Spain & Rest of Europe)
- Asia Pacific (China, India, ASEAN, Australia & New Zealand)
- Middle East and Africa (GCC Countries, South Africa, North Africa & Rest of MEA)
Top Players in Lenalidomide industry
- Pfizer
- Intas Pharmaceuticals
- CASI Pharmaceuticals
- Biocon
- Bionomics
- Genentech
- Kyowa Hakko Kirin
- Hetero Drugs
- Genexine
- ImClone Systems
- Five Prime Therapeutics
- Celgene Corporation
- Mabtech Angstrom Pharmaceuticals
- Acceleron Pharma
- Fujifilm Kyowa Kirin Biologics
- Levolta Pharmaceuticals
- Marsala Biotech Allergan
- Alnylam Pharmaceuticals
- Amgen
- Enzon Pharmaceuticals
Key Questions answered by report
- What was the market size trend of 2013-2015?
- What will be the market size trend of next 4-5 years?
- What are the most common brands in terms of volume?
- How much brands available for Lenalidomide?
- Who are the key players of Lenalidomide API?
- What are the major application industries & emerging industries?
- Who are the key vendors present in the market?
- How the future opportunities & market drivers will affect the market dynamics & ongoing trends?
- Which one segment from global coverage will be lucrative & will grow?
- What are the main market opportunities and threats faced by the vendors?
- What are the strategies are following by the existing market players?
CHAPTER 1 RESEARCH METHODOLOGY
CHAPTER 2 REPORT DESCRIPTION
CHAPTER 3 LENALIDOMIDE EXECUTIVE SUMMARY
CHAPTER 4 LENALIDOMIDE BASIC HIGHLIGHTS
- 4.1. Product Overview
- 4.2. CAS No & Molecular Weight
- 4.3. Innovator & Developer Details
- 4.4. Priority & Patent Expiry
- 4.5. Molecular Formula
- 4.6. Market Status
CHAPTER 5 GLOBAL LENALIDOMIDE PHYSICAL FORMS, GRADES & APPLICATION INDUSTRY
- 5.1. Lenalidomide Forms (Anhydrous or Monohydrate)
- 5.2. Lenalidomide Grades Description
- 5.3. Lenalidomide Variants
- 5.4. Lenalidomide Route of Administration
- 5.5. Lenalidomide Synonym
- 5.6. Lenalidomide Type
- 5.6.1. 5 mg Capsules
- 5.6.2. 10 mg Capsules
- 5.6.3. 15 mg Capsules
- 5.6.4. 25 mg Capsules
- 5.7. Lenalidomide Applications
- 5.7.1. Cancer Disease
- 5.7.2. Cardiovascular Disease
- 5.7.3. Immune Disease
CHAPTER 6 LENALIDOMIDE MANUFACTURING PROCESS WITH UPSTREAM & DOWNSTREAM
- 6.1. Lenalidomide Manufacturing Process Routes & Flow Chart
- 6.2. Lenalidomide Upstream & Downstream Products
CHAPTER 7 LENALIDOMIDE BRAND LIST & MECHANISM OF ACTION
- 7.1. Lenalidomide All Global Brands
- 7.2. Lenalidomide Dosage & Their Strengths
- 7.3. Lenalidomide Mechanism of Action
CHAPTER 8 LENALIDOMIDE (FORMULATION) REGION WISE MARKET OVERVIEW
- 8.1. Lenalidomide Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
- 8.2. Lenalidomide Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
- 8.3. Lenalidomide Market Overview In North America (Canada, US & Rest of North America Available)
- 8.4. Lenalidomide Market Overview In South America (Brazil, Argentina & Rest of South America Available)
- 8.5. Lenalidomide Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)
CHAPTER 9 LENALIDOMIDE (API) REGION WISE MARKET OVERVIEW
- 9.1. Lenalidomide Market Overview In Asia-Pacific (China, India, South Korea & Rest of Asia Pacific Available)
- 9.2. Lenalidomide Market Overview In Europe (Germany, Russia, United Kingdom & Rest of Europe Available)
- 9.3. Lenalidomide Market Overview In North America (Canada, US & Rest of North America Available)
- 9.4. Lenalidomide Market Overview In South America (Brazil, Argentina & Rest of South America Available)
- 9.5. Lenalidomide Market Overview In Middle East & Africa (GCC Countries, South Africa, North Africa & Rest of MEA Available)
CHAPTER 10 LENALIDOMIDE (API & FORMULATION) CONTINENT & COUNTRY WISE MANUFACTURERS, MANUFACTURING VOLUME & CONTACT OVERVIEW
- 10.1. Lenalidomide Continent Wise Manufacturers
- 10.2. Lenalidomide Continent Wise Manufacturing Volume
- 10.3. Lenalidomide Country Wise Manufacturers
- 10.4. Lenalidomide Country Wise Manufacturing Volume
- 10.5. Lenalidomide Manufacturers Contact Overview
CHAPTER 11 LENALIDOMIDE GLOBAL PRICE TREND ANALYSIS OF LAST 3 YEARS
- 11.1. Lenalidomide Global Price Trend Analysis
- 11.2. Lenalidomide Country Wise Price Trend Analysis
CHAPTER 12 LENALIDOMIDE INTERNATIONAL MARKET OVERVIEW
- 12.1. Global Demand/ Supply & Global Prices
- 12.2. Major Destinations Involved In Trade
- 12.3. Major Manufacturers (Capacities & Prices)
CHAPTER 13 LENALIDOMIDE (FORMULATION) GLOBAL MARKET SIZE & MARKET GROWTH FORECASTING (2016-2021) ANALYSIS
- 13.1. Lenalidomide Global Market Size (Past & Future Forecasting)
- 13.2. Lenalidomide Global Market Growth (Past & Future Forecasting)
- 13.3. Lenalidomide Continent Wise Market Size (Past & Future Forecasting)
- 13.4. Lenalidomide Continent Wise Market Growth (Past & Future Forecasting)
CHAPTER 14 LENALIDOMIDE (FORMULATION) CUSTOMER WISE CONSUMPTION, QUANTITY & CONTACT OVERVIEW
- 14.1. Lenalidomide Global Consumers
- 14.2. Lenalidomide Global Consumers As Per Consumption Quantity
- 14.3. Lenalidomide Continent Wise Consumer
- 14.4. Lenalidomide Continent Wise Consumer As Per Consumption Quantity
- 14.5. Lenalidomide Country Wise Consumer
- 14.6. Lenalidomide Country Wise Consumer As Per Consumption Quantity
- 14.7. Lenalidomide Consumers Contact Overview
CHAPTER 15 LENALIDOMIDE CONTINENT WISE EXPORT/ IMPORT ANALYSIS
- 15.1. Lenalidomide Continent Wise Import Analysis
- 15.2. Lenalidomide Continent Wise Export Analysis
- 15.3. Lenalidomide Country Wise Import Analysis
- 15.4. Lenalidomide Country Wise Export Analysis
CHAPTER 16 LENALIDOMIDE WORLDWIDE SWOT ANALYSIS
- 16.1. Lenalidomide Strength Analysis
- 16.2. Lenalidomide Weakness Analysis
- 16.3. Lenalidomide Opportunity Analysis
- 16.4. Lenalidomide Threat Analysis
CHAPTER 17 LENALIDOMIDE REPORT BASED BUSINESS RECOMMENDATION
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
